Roche-Backed Study Finds Tamiflu Saved Lives In Flu Pandemic

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Using Roche's medicine Tamiflu saved lives during the H1N1 swine flu pandemic four years ago, according to a new scientific study published on Wednesday. The pooled analysis of data, involving more than 29,000 patients from 38 countries, was funded by the Swiss drugmaker which hopes the findings will reassure governments about the value of its flu drug following criticism from some doctors. Jonathan Nguyen-Van-Tam of the University of Nottingham and colleagues found that treatment with neuraminidase inhibitor drugs - principally Tamiflu - reduced the risk of death during the pandemic by 19 percent compared with no treatment.

Help employers find you! Check out all the jobs and post your resume.

Back to news